Preface
Page: i-ii (2)
Author: Prerna Sharma, Sumeet Gupta, Hitesh Malhotra, Bhawna Chopra and Sunil Sharma
DOI: 10.2174/9789815196863124010001
Neglected Tropical Diseases
Page: 1-15 (15)
Author: Garima Malik*, Meenakshi Dhanawat and Kashish Wilson
DOI: 10.2174/9789815196863124010003
PDF Price: $15
Abstract
Neglected tropical diseases (NTDs) are a widespread category of
communicable illnesses that thrive in tropical and subtropical environments. More than
a billion people are affected by these illnesses, which annually drain billions of dollars
from developing nations' economies. The most severely impacted populations are those
who lack access to basic sanitation, live in poverty, and are in close proximity to
disease vectors, domestic animals, and livestock. The World Health Organization
(WHO) is a United Nations department focusing on public health issues. NTDs pose a
significant threat to public health both globally and in India. Lymphatic filariasis (LF),
Visceral Leishmaniasis (VL), Rabies, Soil-Transmitted Helminthic Infections (STH),
and Dengue are the principal parasitic and associated infections that the World Health
Organization (WHO) has designated as neglected tropical diseases (NTDs). These
neglected diseases represent a concern to millions of underprivileged Indians who live
in deplorable conditions. The current chapter examines the common NTDs in India,
their prevalence, the state of control strategies, and obstacles and prospects for NTD
eradication.
Strategies to Overcome the Impact of Neglected Diseases on the World
Page: 16-29 (14)
Author: Namratha MP, Pooja Mittal*, Anjali Sharma and Vishnu Mittal
DOI: 10.2174/9789815196863124010004
PDF Price: $15
Abstract
Neglected tropical diseases (NTDs) are highly prevalent in Sub-Saharan
Africa. In the World Bank's definition of poverty, nearly all people suffer from at least
one NTD. Among the most widespread NTDs are malaria, HIV, and soil-transmitted
helminths like lymphatic filariasis, schistosomiasis, trachoma, and onchocerciasis. A
recent study suggests that NTDs may influence the evolution of HIV and AIDS,
malaria, and tuberculosis. These interactions may be influenced by epidemiological,
immunological, and clinical factors, which may impair the prognosis for those with
HIV/AIDS, TB, or malaria. World Health Organization (WHO) suggests five main
strategies for preventing and controlling NTDs for public health-intensified case
management, vector control, preventive chemotherapy, sanitation, the provision of safe
water, veterinary public health, and hygiene. Despite only using one method and doing
it locally, to control, and eliminate the NTDs, these methods can be used as a mark for
achieving the Sustainable Development Goals as they are mainly found in
disadvantaged regions and environments. The development of pilot projects and
initiatives can help achieve the Millennium Development Goals. The poor and
marginalised could gain from innovative treatments for neglected diseases (particularly
parasite infections) based on sustainability concepts and knowledge of key factors
affecting health.
Current Therapeutic Strategies for the Management of Leprosy
Page: 30-47 (18)
Author: Inderjeet Verma*, Dhirender Singh, Meenakshi Dhanawat and Sumeet Gupta
DOI: 10.2174/9789815196863124010005
PDF Price: $15
Abstract
The chronic infectious condition known as leprosy is brought on by the
bacteria Mycobacterium leprae. Peripheral nerves and the skin are frequently attacked,
which can result in impairments. The incidence of M. leprae infection has decreased in
endemic countries as a result of the WHO's multidrug therapy (MDT) program for
leprosy treatment, but there is still active transmission as evidenced by the high rate of
newly reported cases. It is critical to diagnose leprosy as early as possible, hence
clinical examination and research are required. Leprosy has six subgroups, according to
the Ridley-Jopling classification: Tuberculoid (TT), Borderline Tuberculoid (BT),
Borderline-borderline Mid-borderline (BB), Borderline-lepromatous (BL), Subpolar
Lepromatous (LLs), and Polar Lepromatous (LLp). Based on the type of therapy,
leprosy is categorised into paucibacillary (PB) and multibacillary subtypes (MB). Skin
scraping smears are still the preferred laboratory test for leprosy diagnosis. Depending
on the type of leprosy, whether it belongs to the PB or MB group, the course of
treatment with Multi-Drug Therapy (MDT) is modified. Rifampicin and dapsone are
the recommended regimens for the treatment of PB type, whereas rifampicin, dapsone,
and clofazimine are recommended for MB-type patients. To identify an efficient MDT
treatment and stop the spread of the illness, a correct leprosy diagnosis must be made
by both a physical examination and a laboratory analysis.
Emerging Therapy for Dengue
Page: 48-65 (18)
Author: Inderjeet Verma*, Meenakshi Dhanawat, Garima Malik, Arti Saini and Poonam Bharti
DOI: 10.2174/9789815196863124010006
PDF Price: $15
Abstract
There are over 60 countries where dengue fever is endemic, and 2.5 billion
people could get sick from it. An RNA virus belonging to the Flaviviridae family that
causes acute viral disease dengue is transmitted by Aedes mosquitoes. The presenting
signs may be asymptomatic fever with severe implications such as hemorrhagic fever
and shock. The most common symptoms are acute-onset high fever, cutaneous rash,
hemorrhagic episodes, myalgia and circulatory shock. Although oral symptoms are
seldom the primary presenting sign of dengue infection, they may occur in certain
cases. Early and precise diagnosis is necessary for lowering mortality. Dengue virus
infections are typically self-limiting, but in tropical and subtropical countries, dengue
infection has become a public health threat. A detailed explanation of dengue virus
infections, clinical symptoms, diagnostic techniques, and preventative measures are all
included in this book chapter.
Lymphatic Filariasis and Dracunculiasis
Page: 66-90 (25)
Author: Anjali Sharma*, Devkant Sharma, Srishti Vats, Akash Kamboj and Prerna Sharma
DOI: 10.2174/9789815196863124010007
PDF Price: $15
Abstract
In poor nations, helminthic illnesses are a major source of social, economic,
and medical problems. These parasite illnesses affect a large number of people, and
there are not enough effective treatments available. It is necessary to step up research
on novel medications and treatments to address this pressing need. The lymphatic
system is hampered by lymphatic filariasis, which can result in aberrant body part
growth and cause discomfort, severe disability, and social stigma. As of 2018, there
were 51 million cases, a 74% decrease from the 2000 commencement of the WHO's
Global Programme to Eradicate Lymphatic Filariasis. With 27 cases documented in
2020, the devastating parasite disease dracunculiasis is almost completely eradicated.
The transmission cycle takes between 10 and 14 months to complete after infection.
The aim of the book chapter is to focus on pathogenesis, diagnosis, available treatment,
and measures to eradicate these infections caused by helminthic parasites, which have
been declared as neglected diseases by the World Health Organization.
Current Therapeutic Strategies for SoilTransmitted Helminthiasis
Page: 91-111 (21)
Author: Ashwani Arya, Suchitra Nishal, Renu Kadian and Manish Dhall*
DOI: 10.2174/9789815196863124010008
PDF Price: $15
Abstract
Soil-transmitted helminths [STH] are described as neglected tropical
disorders (NTDS) since these impose terrific distress and disability, nevertheless, they
can be eradicated or controlled. The pervasiveness of STH is more usual in
rustic/bucolic areas than in city areas. STH signifies the worms present in the intestine
provoking infection in humans and are transmitted/ conveyed via unhygienic/ dirty soil.
“Helminth” denotes a parasitic worm and the causative agents/ chief species that can
harm humans are the hookworms (Ancylostomaduodenale and Necatoramericanus),
whipworms (Trichuristrichiura) and roundworms (Ascarislumbricoides). Various
features namely, Hypersensitivity reaction (Type -1), the response of defective Th2,
mucosal inflammation, volvulus, obstruction of small bowel and intussusception, blood
loss in the mucosa, anaemia, etc. are involved in the pathophysiology of STH. To
control mortality and morbidity, WHO has recommended population-based, specific,
and target-based approaches. The medications recommended by WHO are
Albendazole, Levamisole, Mebendazole, and Pyrantelpamoate as a single dose.
Preclinical studies are being carried out on the ayurvedic and herbal treatments
employing medicinal plants for STH infections as these are compatible with the body
and have fewer side effects. The infection is now considered a major public health
issue; the major role played by poor sanitation and hygiene in addition to this is certain
environmental conditions. Thus, soil-conveyed helminth infections have a primary
influence on socio-economic progress and advancement of society where occurrence
rates are higher as such acquired infections influence the performance of adults to do
work properly and provoke absenteeism amongst school-going children.
Current Therapeutic Strategies for Neurocysticercosis and Leshmaniasis
Page: 112-165 (54)
Author: Nitin Goel*, Arvinder Kaur, Lalit Gupta, Rajiv Sharma, Satvinder Kaur, Vishnu Mittal and Vani Dawar
DOI: 10.2174/9789815196863124010009
PDF Price: $15
Abstract
The most prevalent parasite condition affecting the brain, neurocysticercosis
(NCC), is a well-known contributor to new seizures all over the world including India.
The only prevalent cause of acquired epileptic seizures in underdeveloped nations,
whereas active epilepsy is a common cause in affluent nations, that is cysticercosis, a
parasitic ailment of the neurological structure in humans initiated by the larval stage of
the tapeworm Taenia solium. The location of the cysticercus affects the pathogenesis,
natural history, clinical symptoms, and therapy. For instance, the primary clinical signs
and symptoms differ depending on the type of disease. Seizures or headaches are
generally the first symptoms of parenchymal NCC. Leishmaniasis is brought on by
parasites of the genus Leishmania in the Trypanosomatidae family which is among the
most neglected tropical infectious diseases. Over 20 different Leishmania protozoa
types can cause the complex vector-borne disorder leishmaniasis, which has a variety
of clinical presentations ranging from localised skin ulcers (cutaneous leishmaniasis) to
a systemic illness that can be fatal if left untreated (visceral leishmaniasis). There is not
a single effective Leishmaniasis treatment available now for all species and symptoms.
Furthermore, the present therapeutic approaches frequently do not lead to a
parasitological cure and recurrence in the context of immunodeficiency (i.e., HIV) is an
emerging area that needs further research. So, this review is a discussion of a
combination of all aspects related to Leishmaniasis, and how to use old treatment
methods such as monotherapy along with modern strategies to combat this major health
issue all over the world.
Current Therapeutic Strategies for Buruli Ulcer
Page: 166-181 (16)
Author: Manisha Bhatia, Jasmine Chaudhary*, Akash Jain and Ashwani Dhingra
DOI: 10.2174/9789815196863124010010
PDF Price: $15
Abstract
The skin is a multifaceted organ with varied functions, but its exposure to
various environmental conditions, including exposure to ultraviolet light, trauma, and
infections, makes it more prone to ulcers. Ageing, poor lifestyle, and certain diseases,
like obesity, hypertension, diabetes, etc., further exaggerate the cause. Skin ulcers are
wounds (sores) often caused by reduced blood flow leading to absolute loss of the
epidermal layer along with parts of the dermis or subcutaneous fat, and thus have
tremendously slow healing affinity. Buruli ulcer (BU), or Bairnsdale is a type of
necrotizing skin ulcer mainly caused by the bacterium, Mycobacterium ulcerans, and
characterized initially by the formation of papules or nodules (edematous lesions),
which further progresses to chronic skin ulceration as a result of epidermal hyperplasia,
collagen destruction, and vascular damage in the underlying dermis and subcutis. It is
considered one of the 20 neglected diseases of the skin by the World Health
Organization (WHO). Although scattered in more than 33 countries, its prevalence is
the highest in West Africa and this incidence has risen manifold during the last few
years, which might be due to deforestation, artificial topographic alterations, and
increased manual agriculture. Mycolactone, a polyketide-based immunosuppressive
macrolide, is considered the major factor responsible for the pathogenesis of the
disease. Its high toxicity dampens the immune system, causing extensive tissue
destruction mainly in skin cells and minute blood vessels, leading to ulceration and
skin loss. Generally, a combination of rifampicin with streptomycin, amikacin,
clarithromycin, or ciprofloxacin along with oral prednisolone for eight weeks is
specified as a first-line treatment. Surgery to remove necrotic tissue, BCG vaccination
for short-term protection, and physiotherapy to promote healing are also found
beneficial. To combat this deadly disease, enhanced public education and awareness
through outreach initiatives is a must as prevention is always considered better than
cure. Further studies in this area may be helpful in investigating more treatment
regimens along with various ways by which the occurrence of Buruli ulcer can be
avoided. The present study is therefore designed to compile all relevant literature,
which can serve as an important lead for further investigations in this area of research.
Current Therapeutic Strategies for Trachoma
Page: 182-199 (18)
Author: Himani Bajaj, Sindhu Agarwal*, Anjali Sharma, Mayank Yadav and Md. Arif Naseer
DOI: 10.2174/9789815196863124010011
PDF Price: $15
Abstract
As a result of persistent follicular conjunctivitis brought on by Chlamydia
trachomatis and consequent corneal scarring, about 6 million people have irreparable
blindness. Chlamydia trachomatis is a bacterium that causes trachoma, an eye
infection. Early signs include eyelid itchiness and irritation, whereas advanced signs
include swollen eyelids, pus oozing from the eyes, photophobia (light sensitivity),
discomfort in the eye, and vision issues. Using the SAFE strategy, the WHO is driving
an international campaign to eradicate Blinding Trachoma. Trichiasis surgery,
antibiotic treatment for infection, hygiene promotion on the face, and environmental
changes to improve air quality are all part of this. The best antibacterial medication for
widespread distribution is oral azithromycin.
Current Therapeutic Strategies for Food Borne Trematodiases
Page: 200-214 (15)
Author: Nidhi Gupta*, Inderjeet Verma and Hasandeep Singh
DOI: 10.2174/9789815196863124010012
PDF Price: $15
Abstract
Food-borne trematodiases are among the neglected tropical diseases caused
due to liver flukes (Clonorchissinensis, Fasciolagigantica, Opisthorchis vivernii), lung
flukes (Paragonimus spp.) and intestinal parasitic flukes (Echinostoma spp.) infections
and is an emerging public health problem. They are mostly found in developing
countries and in areas where they are present, they aggravate poverty. However, they
are no longer being neglected because of their broad geographical distribution, a wide
range of infected people, and measures available to control several neglected tropical
diseases. WHO estimates that every year two million people are suffering from
disability and death due to these neglected diseases. The treatment of food-borne
trematodiases, a neglected disease, is important for preventing the progression of
clinical diseases and reducing the associated morbidity. In the present chapter, we will
discuss the food-borne trematodes’ life cycle, associated symptoms, diagnosis and
various strategies used in treating food-borne trematodiases. Currently used
chemotherapeutic drugs, their safety, therapeutic profile, and resistance developed are
summarized here. Furthermore, emphasis is given to developing a broad-spectrum
trematocidal drug with high safety and efficacy.
Subject Index
Page: 215-219 (5)
Author: Prerna Sharma, Sumeet Gupta, Hitesh Malhotra, Bhawna Chopra and Sunil Sharma
DOI: 10.2174/9789815196863124010013
Introduction
This reference provides an update on current therapies to treat neglected diseases, a class of diseases that primarily affect tropical regions where investment in research and development is limited. The book starts with an introduction to neglected diseases followed by reviews of therapeutic strategies to overcome the impact of neglected diseases. This is followed by updated information for handling leprosy, dengue, lymphatic filariasis, dracunculiasis, helminthiasis, Chagas’ disease, neurocysticercosis, leishmaniasis, rabies, trematodiasis, buruli ulcer and trachoma in 10 focused chapters, respectively. The chapters provide information on disease mechanism, transmission and management protocols, along with scientific references. The book serves as a resource for healthcare professionals, and scholars who need a detailed understanding of these infectious diseases.